OUR TRACK RECORD SPEAKS FOR ITSELF
NeXeption is the partner of choice for accelerating therapies through clinical and regulatory milestones
NeXeption builds innovative companies by bringing together pharmaceutical product opportunities, management expertise and the necessary funding to rapidly advance therapies through clinical and regulatory milestones.
Our experienced team of pharmaceutical and biotechnology executives has a proven track record of identifying, developing, registering and commercializing new products. The following companies formed by members of the management team have been successfully partnered, generating high returns for investors.
How we're different
Our unique business model creates, funds and manages independent operating companies focused solely on maximizing the value of each potential opportunity. We target programs that address unmet medical needs and have a high technical probability of success.
FOR PHARMA COMPANIES
we offer an alternative pipeline development path for non-progressing assets or science.
FOR INVENTORS AND ENTREPRENEURS
we provide the appropriate resources and access to capital to advance assets from concept through commercialization.
we have a consistent track record of high returns.
NeXeption is actively seeking additional development-ready assets across a broad range of therapeutic areas.
Based in Philadelphia
One of the nation's largest R&D hubs and
growing center of healthcare innovation
NeXeption is a biopharmaceutical management company that brings together product opportunities, management expertise and the necessary funding to reach compelling partnership milestones. The NeXeption management team has a proven track record in raising capital, operating development stage companies and forming strategic partnerships to advance products for the benefit of patients.